Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy (Proceedings of the National Academy of Sciences (December 24, 1996) 93 (15346-15351))

E. G. Hanania, R. E. Giles, J. Kavanagh, S. Q. Fu, D. Ellerson, Z. Zu, T. Wang, Y. Su, A. Kudelka, Z. Rahman, F. Holmes, G. Hortobagyi, D. Claxton, C. Bachier, P. Thall, S. Cheng, J. Hester, J. M. Ostrove, R. E. Bird, A. ChangM. Korbling, D. Seong, R. Cote, T. Holzmayer, E. Mechetner, S. Heimfeld, R. Berenson, B. Burtness, C. Edwards, B. Bast, M. Andreeff, R. Champlin, A. B. Deisseroth

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalProceedings of the National Academy of Sciences of the United States of America
Volume94
Issue number10
StatePublished - Jan 1 1997
Externally publishedYes

ASJC Scopus subject areas

  • General

Cite this

Hanania, E. G., Giles, R. E., Kavanagh, J., Fu, S. Q., Ellerson, D., Zu, Z., Wang, T., Su, Y., Kudelka, A., Rahman, Z., Holmes, F., Hortobagyi, G., Claxton, D., Bachier, C., Thall, P., Cheng, S., Hester, J., Ostrove, J. M., Bird, R. E., ... Deisseroth, A. B. (1997). Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy (Proceedings of the National Academy of Sciences (December 24, 1996) 93 (15346-15351)). Proceedings of the National Academy of Sciences of the United States of America, 94(10).